United States Healthcare Equipment & Supplies

Caris Life Sciences Inc (CAI)

Track

Caris Life Sciences witnessed four insider trading transactions recently, totaling a net value of approximately 1.49 million dollars. Director George H. Poste initiated proposed sales following the company's latest earnings report, which showed a significant miss. Despite these divestments, overall buying activity remains present, reflecting varied sentiment among key stakeholders regarding current market performance.
Ticker: CAI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Caris Life Sciences Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 7 Aug 2026
Value US$378,115.33 | Price 332.14 | Shares 70,563
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-07 PrS Proposed sale
2.6
GEORGE H POSTE

Director

Non-Executive Director
70,563
332.14
US$378,115 		70,563 332.14 US$378,115
2026-08-03 2026-08-03 PrS Proposed sale
2.6
GEORGE H POSTE

Director

Non-Executive Director
35,205
94.10
US$1,779,829 		35,205 94.10 US$1,779,829
2026-07-13 2026-05-15 B Purchase
HALBERT JON
Non-Executive Director
88,637 -19.7%
495.95
US$386,401 		88,637 -19.7% 495.95 US$386,401
2026-05-12 2026-05-11 B Purchase
2.6
Vacirca Jeff L
Non-Executive Director
31,050 +166.7%
16.15
US$501,426 		31,050 +166.7% 16.15 US$501,426
2025-12-12 2025-12-11 PlS Planned sale
Power Luke Thomas

See Remarks

Officer
1,400 -1.4%
27.16
US$38,018 		1,400 -1.4% 27.16 US$38,018
2025-12-12 2025-12-11 PlS Planned sale
Power Luke Thomas

See Remarks

Officer
60,850 -37.6%
26.56
US$1,616,444 		60,850 -37.6% 26.56 US$1,616,444
2025-12-11 2025-12-11 PrS Proposed sale
LUKE POWER

Officer

Officer
62,250
27.10
US$1,686,975 		62,250 27.10 US$1,686,975
2025-11-10 2025-11-07 B Purchase
1.6
Denton John Russel

See Remarks

Officer
4,184 +83.7%
24.09
US$100,793 		4,184 +83.7% 24.09 US$100,793
2025-11-10 2025-11-07 B Purchase
1.6
Spetzler David Baxley

President

Officer
400 +0.1%
23.85
US$9,540 		400 +0.1% 23.85 US$9,540
2025-06-23 2025-06-20 B Purchase
1.6
Denton John Russel

See Remarks

Officer
7,500 +6.5%
21.00
US$157,500 		7,500 +6.5% 21.00 US$157,500
2025-06-23 2025-06-20 B Purchase
Brille Brian J

See Remarks

Executive Director
30,000 +22.7%
21.00
US$630,000 		30,000 +22.7% 21.00 US$630,000
Explore more

More insider trading research around Caris Life Sciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America